Skip to main content

San Martin Quoted in Life Sciences Intellectual Property Review on UK Supreme Court Drug Patent Decision

July 16, 2021

Intellectual Property partner Dr. Beatriz San Martin was quoted in a Life Sciences Intellectual Property Review article, "UK Supreme Court Shoots Down NHS £220m Drug Patent Suit." The article discusses a recent ruling by the UK Supreme Court that the British government cannot avail itself of the tort of unlawful means in its £220 million damages claim against an international pharmaceutical company for allegedly misrepresenting its blood pressure drugs patent in legal proceedings to block generic competitors from entering the market.

» Read the full article (subscription required).